Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study. - Maffezzoli M; Signori A; Acunzo A; Buti S; Bosoni M; Verzoni E; Di Marco A; Lolli C; Di Napoli M; Fanelli M; Volta AD; Masini C; et al. (Cancer immunology, immunotherapy : CII, 2026)